Evidence map›Paper›PMID 38517786›Full record

ArticleJournal of Alzheimer's disease : JAD2024

Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.

Valeria Cogut, Taylor L McNeely, Tyler J Bussian, Sara I Graves, Darren J Baker

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Valeria CogutDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Taylor L McNeelyDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Tyler J BussianDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Sara I GravesDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Darren J BakerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · US

Funding

The contribution of p16-expressing cells to tauopathyR01AG053229 · NIA · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2017 to 2021
$2.0M
Effects of senescence to Alzheimer's disease pathologyR01AG068076 · NIA · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2020 to 2024
$2.0M
NIA NIH HHS R01 AG053229NIA NIH HHS R01 AG068076
6 · The paper itself

Abstract

Background: Caloric restriction (CR) has been recognized for its benefits in delaying age-related diseases and extending lifespan. While its effects on amyloid pathology in Alzheimer's disease (AD) mouse models are well-documented, its effects on tauopathy, another hallmark of AD, are less explored. Objective: To assess the impact of a short-term 30% CR regimen on age-dependent spatial learning deficits and pathological features in a tauopathy mouse model. Methods: We subjected male PS19 tau P301S (hereafter PS19) and age-matched wildtype mice from two age cohorts (4.5 and 7.5 months old) to a 6-week 30% CR regimen. Spatial learning performance was assessed using the Barnes Maze test. Tau pathology, neuroinflammation, hippocampal cell proliferation, and neurogenesis were evaluated in the older cohort by immunohistochemical staining and RT-qPCR. Results: CR mitigated age-dependent spatial learning deficits in PS19 mice but exhibited limited effects on tau pathology and the associated neuroinflammation. Additionally, we found a decrease in hippocampal cell proliferation, predominantly of Iba1+ cells. Conclusions: Our findings reinforce the cognitive benefits conferred by CR despite its limited modulation of disease pathology. Given the pivotal role of microglia in tau-driven pathology, the observed reduction in Iba1+ cells under CR suggests potential therapeutic implications, particularly if CR would be introduced early in disease progression.

Indexed as

Alzheimer DiseaseTauopathiesAnimalsCaloric RestrictionDisease Models, AnimalHumansMaleMaze LearningMiceMice, TransgenicNeuroinflammatory DiseasesSpatial Learningtau Proteinstau ProteinsAlzheimer’s diseasecalorie restrictionmicrogliaspatial learningtauopathy

Identifiers

PMID38517786
PMCPMC11068089
OpenAlexW4392949235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.